Zobrazeno 1 - 10
of 132
pro vyhledávání: '"Marcel Reiser"'
Autor:
Lisa Falchetto, Bernd Bender, Ian Erhard, Kim N. Zeiner, Jan A. Stratmann, Florestan J. Koll, Sebastian Wagner, Marcel Reiser, Khayal Gasimli, Angelika Stehle, Martin Voss, Olivier Ballo, Jörg Janne Vehreschild, Daniel Maier
Publikováno v:
BMC Research Notes, Vol 17, Iss 1, Pp 1-6 (2024)
Abstract Objective The concept of lines of therapy (LOT) in cancer treatment is often considered for decision making in tumor boards and clinical management, but lacks a common definition across medical specialties. The complexity and heterogeneity o
Externí odkaz:
https://doaj.org/article/2ddb10a220324f82a22c2648f4c609fc
Autor:
Frank Griesinger, MD, PhD, Wilfried E.E. Eberhardt, MD, PhD, Wolfgang M. Brueckl, MD, PhD, Horst-Dieter Hummel, MD, PhD, Bastian Jaeschke, MD, Jens Kern, MD, Claas Wesseler, MD, Martina Jänicke, PdD, Annette Fleitz, PhD, Stefan Zacharias, PhD, Annette Hipper, PhD, Annika Groth, MD, PhD, Wilko Weichert, MD, PhD, Steffen Dörfel, Volker Petersen, MD, Jan Schröder, MD, Jochen Wilke, MD, Martin Sebastian, MD, Michael Thomas, MD, PhD, Juliana Ababei, Jürgen Alt, Andreas Ammon, Jürgen Anhuf, Ivo Azeh, Stefan Bauer, Dirk Behringer, Winfried Berger, Christiane Bernhardt, Mathias Bertram, Michael Boesche, Sabine Bohnet, Harald-Robert Bruch, Wolfgang Brückl, Ulrike Burkhard-Meier, Petros Christopoulos, Klaus-Ulrich Däßler, Maike de Wit, Tobias Dechow, Reinhard Depenbusch, Lutz Dietze, Markus Dommach, Wilfried Eberhardt, Corinna Elender, Wolfgang Elsel, Till-Oliver Emde, Martin Faehling, Thomas Fietz, Jürgen R. Fischer, Dimitri Flieger, Anke Freidt, Werner Freier, Christian Frenzel, Florian Fuchs, Roswitha Fuchs, Tobias Gaska, Wolfgang Gleiber, Christian Grah, Frank Griesinger, Christian Grohé, Matthias Groschek, Björn Güldenzoph, Andreas Günther, Siegfried Haas, Matthias Hackenthal, Volker Hagen, Lars Hahn, Verena Hannig Carla, Richard Hansen, Hanns-Detlev Harich, Monika Heilmann, Kathrin Heinrich, Christiane Hering-Schubert, Jörg Heßling, Petra Hoffknecht, Patricia Hortig, Gerdt Hübner, Horst-Dieter Hummel, Ulrich Hutzschenreuter, Thomas Illmer, Georg Innig, Bastian Jaeschke, Christian Junghanß, Ulrich Kaiser, Haytham Kamal, Kato Kambartel, Jens Kern, Martin Kimmich, Dorothea Kingreen, Heinz Kirchen, Martine Klausmann, Ortwin Klein, Konrad Kokowski, Wolfgang Körber, Cornelius Kortsik, Dirk Koschel, Benoit Krämer, Beate Krammer-Steiner, Eckart Laack, Christof Lamberti, Rumo David Leistner, Christoph Losem, Andreas Lück, Christoph Maintz, Kerstin Martin, Dirk Medgenberg, Martin Metzenmacher, Christian Meyer zum Büschenfelde, Philipp Meyn, Enno Moorahrend, Annette Müller, Lothar Müller, Michael Neise, Holger Nückel, Arnd Nusch, Tobias Overbeck, Henning Pelz, Volker Petersen, Bettina Peuser, Margarete Plath, Winfried J. Randerath, Jacqueline Rauh, Martin Reck, Dietmar Reichert, Niels Reinmuth, Marcel Reiser, Roland Repp, Daniel Reschke, Achim Rittmeyer, Yolanda Rodemer, Sandra Sackmann, Parvis Sadjadian, Reiner Sandner, Annette Sauer, Harald Schäfer, Christoph Schaudt, Rudolf Schlag, Burkhard Schmidt, Stephan Schmitz, Jan Schröder, Michael Schroeder, Mathias Schulze, Christian Schumann, Wolfgang Schütte, Martin Schwaiblmair, Florian Schwindt Peter, Martin Sebastian, Bernd Seese, Gernot Seipelt, Thomas Sorgenfrei, Johannes Steiff, Heike Steiniger, Tanja Trarbach, Amanda Tufman, Jens Uhlig, Ursula Vehling-Kaiser, Eyck von der Heyde, Ulla von Verschuer, Cornelius Waller, Thomas Wehler, Georg Weißenborn, Florian Weißinger, Martin Wermke, Claas Wesseler, Jörg Wiegand, Stefan Wilhelm, Jochen Wilke, Mark-Oliver Zahn, Matthias Zaiss, Matthias Zeth
Publikováno v:
JTO Clinical and Research Reports, Vol 5, Iss 4, Pp 100626- (2024)
Introduction: Patients with metastatic NSCLC (mNSCLC) treated with immune checkpoint inhibitors in clinical practice may often not meet the strict inclusion criteria of clinical trials. Our aim was to assess the trial eligibility of patients with mNS
Externí odkaz:
https://doaj.org/article/193c505adea04fdda590997c6e7e69c0
Autor:
Petra Langerbeins, Sandra Robrecht, Pascal Nieper, Paula Cramer, Moritz Fürstenau, Othman Al-Sawaf, Anna-Maria Fink, Karl-Anton Kreuzer, Ursula Vehling-Kaiser, Eugen Tausch, Christof Schneider, Lothar Müller, Michael Eckart, Rudolf Schlag, Werner Freier, Tobias Gaska, Christina Balser, Marcel Reiser, Martina Stauch, Clemens Wendtner, Kirsten Fischer, Stephan Stilgenbauer, Barbara Eichhorst, Michael Hallek
Publikováno v:
HemaSphere, Vol 7, p e9488123 (2023)
Externí odkaz:
https://doaj.org/article/33372e691aa14d76b419724406bb6917
Autor:
Georg-Nikolaus Franke, Gunnar Loewe, Marcel Reiser, Hartmut Linde, Andreas Josting, Eyck von der Heyde, Rudolf Weide, Hans Tesch, Arndt Nusch, Jolanta Dengler, Kathleen Jentsch-Ullrich
Publikováno v:
HemaSphere, Vol 7, p e4962270 (2023)
Externí odkaz:
https://doaj.org/article/e75f25079aee4426a4e5fc7952668e0c
Autor:
Michael Kusch, Hildegard Labouvie, Vera Schiewer, Natalie Talalaev, Jan C. Cwik, Sonja Bussmann, Lusine Vaganian, Alexander L. Gerlach, Antje Dresen, Natalia Cecon, Sandra Salm, Theresia Krieger, Holger Pfaff, Clarissa Lemmen, Lisa Derendorf, Stephanie Stock, Christina Samel, Anna Hagemeier, Martin Hellmich, Bernd Leicher, Gregor Hültenschmidt, Jessica Swoboda, Peter Haas, Anna Arning, Andrea Göttel, Kathrin Schwickerath, Ullrich Graeven, Stefanie Houwaart, Hedy Kerek-Bodden, Steffen Krebs, Christiana Muth, Christina Hecker, Marcel Reiser, Cornelia Mauch, Jennifer Benner, Gerdamarie Schmidt, Christiane Karlowsky, Gisela Vimalanandan, Lukas Matyschik, Lars Galonska, Annette Francke, Karin Osborne, Ursula Nestle, Markus Bäumer, Kordula Schmitz, Jürgen Wolf, Michael Hallek
Publikováno v:
BMC Health Services Research, Vol 22, Iss 1, Pp 1-31 (2022)
Abstract Background The annual incidence of new cancer cases has been increasing worldwide for many years, and is likely to continue to rise. In Germany, the number of new cancer cases is expected to increase by 20% until 2030. Half of all cancer pat
Externí odkaz:
https://doaj.org/article/22ee96b5f5de4f9f8f3db5841d8d5e14
Autor:
C. Benedikt Westphalen, Tobias Kukiolka, Benjamin Garlipp, Lars Hahn, Martin Fuchs, Peter Malfertheiner, Marcel Reiser, Fabian Kütting, Volker Heinemann, Andreas Beringer, Dirk T. Waldschmidt
Publikováno v:
BMC Cancer, Vol 20, Iss 1, Pp 1-8 (2020)
Abstract Background Gemcitabine/erlotinib treatment offers limited benefit in unselected patients with pancreatic ductal adenocarcinoma (PDAC). Development of skin rash has been associated with favorable outcomes in patients treated with gemcitabine/
Externí odkaz:
https://doaj.org/article/0484dbc7c1e94e40ba3604fe80c2ce56
Autor:
Ulrich Dührsen, Stefanie Broszeit‐Luft, Annette Dieing, Andreas Lück, Piotr Porowski, Marcel Reiser, Ulrike Schwinger, Sandra Klawitter, Katja Krumm, Kathleen Jentsch‐Ullrich
Publikováno v:
Cancer Medicine, Vol 7, Iss 7, Pp 2903-2912 (2018)
Abstract Standard of care for patients with symptomatic, advanced‐stage follicular lymphoma (FL) is rituximab‐containing chemoimmunotherapy followed by rituximab maintenance. This prospective, multicenter, noninterventional study analyzed how eff
Externí odkaz:
https://doaj.org/article/8d0721bd9e7f4b1aaea286c0d1dfc014
Autor:
Alexander C. Bunck, Daniel Pinto dos Santos, De-Hua Chang, Marcel Reiser, David Pfister, Anne Bunck, Alexander Drzezga, David Maintz, Matthias Schmidt
Publikováno v:
Case Reports in Oncology, Vol 10, Iss 2, Pp 627-633 (2017)
Prostate cancer is the most common solid tumor malignancy worldwide with an estimated 180,000 new cases of prostate cancer and 26,000 deaths in the USA in 2016. Although significant advances in the treatment of prostate cancer have recently been made
Externí odkaz:
https://doaj.org/article/265f2a2860784b1ab5bac82757a33a39
Autor:
Martin Stangel, Ralf Gold, David Pittrow, Ulrich Baumann, Michael Borte, Maria Fasshauer, Manfred Hensel, Dörte Huscher, Marcel Reiser, Claudia Sommer
Publikováno v:
Therapeutic Advances in Neurological Disorders, Vol 9 (2016)
Objectives: The management of patients with multifocal motor neuropathy (MMN) under everyday clinical conditions has been insufficiently studied. We therefore collected comprehensive observational data on patients with MMN who received intravenous (I
Externí odkaz:
https://doaj.org/article/a3e12196c6d44958a2f3319aa76d18e8
Autor:
Agnieszka Korfel, Thomas Elter, Eckhard Thiel, Matthias Hänel, Robert Möhle, Roland Schroers, Marcel Reiser, Martin Dreyling, Jan Eucker, Christian Scholz, Bernd Metzner, Alexander Röth, Josef Birkmann, Uwe Schlegel, Peter Martus, Gerard Illerhaus, Lars Fischer
Publikováno v:
Haematologica, Vol 98, Iss 3 (2013)
The prognosis of patients with central nervous system relapse of aggressive lymphoma is very poor with no therapy established so far. In a prospective multicenter phase II study, we evaluated a potentially curative chemotherapy-only regimen in these
Externí odkaz:
https://doaj.org/article/95754aed9f7d4e509c4cca9f6adb1d8d